All In Biotech

Drug Trial Radar · NCT00109551

Community Trial of Zinc Supplementation on Preschool Child Mortality and Morbidity in Southern Nepal

Zinc Supplementation Impact on Child Mortality--Nepal

Last checked: Nov 19, 2026Latest source record: May 1, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 58,000 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

58,000

Actual

Start

Oct 2001

Primary completion

Not stated

Study completion Jan 2006

Sponsor

Sponsor type
NIH
Collaborators
United States Agency for International Development (USAID); Bill and Melinda Gates Foundation
First posted
Apr 29, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Factorial
Masking
Double
Primary purpose
Prevention
Who can join
All sexes, from 1 month, up to 36 months
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether daily supplementation of young children in Nepal with either zinc, iron-folic acid, or both can reduce mortality and morbidity. Young children in Nepal have numerous nutritional deficiencies and high rates of morbidity and mortality. Zinc and/or iron supplementation may be a cost-effective method for reducing these risks.

Conditions

  • Nutrition

Interventions

  • zinc sulphate dietary supplementDrug

  • iron sulphate-folic acid dietary supplementDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Death among children 1-36 months of age

Locations

3 sites in 2 countries. Site status is shown where the registry gives one.

  • Johns Hopkins Bloomberg School of Public Health

    Baltimore, Maryland

  • Cornell University Division of Nutritional Sciences

    Ithaca, New York

  • Nepal Nutrition Intervention Project-Sarlahi

    Kathmandu and Sarlahi District, Nepal

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.